Spruce Biosciences, Inc. (SPRB) Tops Q1 EPS by 8c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q1 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $2 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• KeyBanc Starts Eastman Chemical (EMN) at Sector Weight
• Adobe Systems (ADBE) Tops Q3 EPS by 6c, Offers Guidance